
HSBC · NYSE
The supplied consensus is Hold across 10 analysts, with a mean target of 113.12; low and high targets are not provided, so the target spread cannot be measured. The evidence does not name the most bullish or least bullish analyst, identify individual ratings, or report any target revisions during the week. It therefore supports a neutral aggregate view but not a meaningful ranking of analyst conviction. The substantive disagreement visible in the supplied material is between the potential value of HSBC’s buy-back and portfolio reshaping, including the Australian deposit sale, and concern that capital deployment, higher rates, or weaker operating conditions may not translate into stronger earnings. No reported financials are available to resolve that debate.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| BNP Paribas Exane | — | — | — | Aug 4, 2026 | Open the report this row came from | |
| Citigroup Inc. | — | — | — | Aug 4, 2026 |